Synthetic cannabinoid dependence, early full remission (Q40338): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/2648920
@@ Property / Canonical URI: https://id.who.int/icd/entity/2648920 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:6C42.21
@@ Property / CURIE: CID11:6C42.21 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-6C42.21
@@ Property / Canary Token: dki-india-6C42.21 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+F12.2
@@ Property / Linked ICD 10: F12.2 / rank @@
+Normal rank

Latest revision as of 06:06, 13 August 2026

After a diagnosis of synthetic cannabinoid dependence, and often following a treatment episode or other intervention (including self-help intervention), the individual has been abstinent from synthetic cannabinoid use during a period lasting between 1 and 12 months.

Language	Label	Description	Also known as
default for all languages	6C42.21
English	Synthetic cannabinoid dependence, early full remission	After a diagnosis of synthetic cannabinoid dependence, and often following a treatment episode or other intervention (including self-help intervention), the individual has been abstinent from synthetic cannabinoid use during a period lasting between 1 and 12 months.